Compounds > technetium tc 99m sestamibi
Page last updated: 2024-08-16

technetium tc 99m sestamibi and Mastitis

technetium tc 99m sestamibi has been researched along with Mastitis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Becker, I; Brinkbäumer, K; Hahn, K; Kessler, M; Linke, R; Sommer, H; Tiling, R; Untch, M1
Fleming, RM1

Trials

1 trial(s) available for technetium tc 99m sestamibi and Mastitis

ArticleYear
Mitochondrial uptake of sestamibi distinguishes between normal, inflammatory breast changes, pre-cancers, and infiltrating breast cancer.
    Integrative cancer therapies, 2002, Volume: 1, Issue:3

    Topics: Adult; Aged; Breast; Breast Neoplasms; Diagnosis, Differential; Dipyridamole; Female; Humans; Male; Mastitis; Middle Aged; Mitochondria; Radionuclide Imaging; Radiopharmaceuticals; Reference Values; Regional Blood Flow; Technetium Tc 99m Sestamibi; Vasodilator Agents

2002

Other Studies

1 other study(ies) available for technetium tc 99m sestamibi and Mastitis

ArticleYear
[Breast scintigraphy using 99mTc-sestamibi--use and limitations].
    Nuklearmedizin. Nuclear medicine, 2002, Volume: 41, Issue:3

    Topics: Breast; Breast Neoplasms; Female; Fibrocystic Breast Disease; Humans; Magnetic Resonance Imaging; Mastitis; Papilloma; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Technetium Tc 99m Sestamibi

2002